Hi LJohn,
Thanks for feedback. Yes I tend to agree with PharmD. I think there are more chances of it being submitted rather than not and much before FDA approval. I like everyone else, am waiting patiently for the stated update in Q4...only then we will have a better idea of the status.
I don't recall anything being said on the matter in the Bells presentation and if it was it would have just been in passing, I definitely did not note anything down on the topic.
Ann: Paradigm Presentation to Emerging Leaders Conference, page-62
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $104.9M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 29.5¢ | $89.62K | 294.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20607 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 16773 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |